Deals

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery
Eli LillyHKG: 7666

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery

METiS TechBio (HKG: 7666), an innovative AI drug delivery company, announced a strategic collaboration with Eli Lilly and Company (NYSE: LLY) focused on the research and discovery of novel lipid…

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang
AdiconHKG: 9860

Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies
CAR-TCell-therapy

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment
Alchemab TherapeuticsEli Lilly

Alchemab Therapeutics Licenses ATLX-1282 to Eli Lilly for ALS Treatment

EndoCell Secures RMB 200 Million in Financing to Advance Islet Regeneration Technology
Cell-therapyEndoCell Biotech

EndoCell Secures RMB 200 Million in Financing to Advance Islet Regeneration Technology

Show More